Polaprezinc is a chelated form of zinc and L-carnosine. It is a zinc-related medicine approved for the first time in Japan, which has been clinically used to treat gastric ulcers. It was determined that polaprezinc may be effective in pressure ulcer treatment. A study in 2013 showed that CO-administration of polaprezinc may be effective against small intestine mucosal injury associated with long-term aspirin therapy. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Zinc Carnosine, Zinc L-carnosine, AHZ-zinc and Promac. Its PubChem CID is 9817450.
Polaprezinc
| CAS No | 107667-60-7 |
|---|---|
| Molecular Formula | C9H12N4O3Zn |
| Molecular Weight | 289.6 g/mol |
| Synonyms | zinc;(2S)-2-(3-aminopropanoylamino)-3-imidazol-1-id-4-ylpropanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Polaprezinc is a chelated form of zinc and L-carnosine. It is a zinc-related medicine approved for the first time in Japan, which has been clinically used to treat gastric ulcers.
The listed CAS number is 107667-60-7.
The listed molecular formula is C9H12N4O3Zn.
The listed molecular weight is 289.6 g/mol.
zinc;(2S)-2-(3-aminopropanoylamino)-3-imidazol-1-id-4-ylpropanoate.
The source lists Zinc Carnosine, Zinc L-carnosine, AHZ-zinc and Promac.